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COVID-19 is rapidly changing our lives
The COVID-19 pandemic is one of the most extreme challenges that 
we have ever met in our professional practice. Urgent responses to 
the pandemic have impeded normal work and dramatically changed 
the daily routine activities of much of the world’s population. For all 
health-care workers, the pandemic has completely disrupted normal 
medical practice and daily work. Obviously, physicians and nurses are 
inevitably thrown into the middle of the pandemic, and they are forced 
to protect both patients and themselves. The occurrence of illness and 
the obligation to undergo quarantine frequently lead to staff shortage, 
which makes the work even more difficult [1]. At present, we protect our 
patients against infection; soon we might have to treat them for both 
hematological disease and COVID-19 infection. This situation will drive 
further organizational changes in hospitals and within individual wards.
Lessons from the ongoing COVID-19 pandemic
The five most important lessons that the pandemic has taught me up to 
mid-April 2020 are as follows:
1.  Organization of the physician’s practice and workplace is changing 
considerably: We know that a new division of duties in the clinical 
team is possible, that is, some people can work remotely, others 
can conduct research, and yet others can involve solely in teaching. 
These duties can be rotated. Our departments had to solve many 
problems and provisional solutions have been implemented; some 
of them can already be regarded as revolutionary, and some of 
them will be used as a regular and lasting new practice.
2.  Postulated new model of health care for patients is feasible: Some 
patients do not have to visit a doctor or go to a hospital so often. 
The need to produce administrative documentation in many cases 
disrupts the efficient work of physicians, does not help our patients, 
and is not necessary. Many procedures can be simplified to the 
benefit of physicians and patients. The pandemic has shown the 
need for a digital revolution in health care.
3.  Accurate information is priceless at the appropriate time and place: 
The pandemic has taught us that fresh and authentic data on 70 
patients can be much more valuable than large cohort studies 
lasting many years.
4.  Exchange of medical data and experience is crucial for everyone: 
The pandemic has demonstrated that 1-h teleconference or 
webinar might be more efficient than a 1-day meeting, and 
nobody has to travel anywhere. We have been presented with 
evidence confirming that there are too many medical and scientific 
conferences nowadays. Nobody has the right to keep knowledge to 
him/herself and plays his/her own game with it.
5.  Knowledge is the true value: The pandemic actually shows that 
what the world looks like without just one vaccine. I hope that this 
is sufficiently a clear signal for anti-vaccine advocates [2, 3]. It is 
a warning for populists, who lack expert knowledge and whose 
programs are based on ignorance. In the period of pandemic, there 
is only one enemy and cooperation is mandatory so that we can 
find ourselves in the right and safe place in the post-pandemic era. 
We all are responsible for the advancement of true knowledge.
Our tasks
The rapid development of the pandemic and the lack of relevant 
evidence-based guidelines have resulted in the creation of a number 
of web-published recommendations and the organization of webinars. 
Such initiatives are very useful and can successfully replace journal 
publications and medical conferences. On the other hand, the 
unexpected abundance of the said online content and events has 
obscured the essence of our main professional objectives during the 
pandemic:
1.  Treatment of primary disease is the priority: Delay in timely 
chemotherapy or any other anticancer therapy undoubtedly leads 
to progression of malignancy and, consequently, a life-threatening 
condition. We have to deliver safe treatments to our patients, such 
as chemotherapy, targeted therapy, blood component therapy, 
and supportive therapy. We cannot delay the administration of 
chemotherapy because of the risk of contracting infection from the 
patient.
2.  Ensuring protective environment for patients and ourselves: It can 
be done by adhering to the principles of nonspecific prevention 
and specific prophylaxis, following local, national, and international 
guidelines, and finally using our common sense, which is equipped 
with knowledge acquired from medical studies and experience 
gained during professional practice. Prevention against the virus 
is of utmost importance, as we cannot treat malignancy when 
a patient suffers from severe COVID-19 pneumonia.
3.  Recommendations are useful, but we have to stick to the rules in 
our hospital: It is mandatory to follow the basic principles of infection 
control. The local and national law can determine the adequate 
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procedures. However, it is impossible to predict everything, so 
we have to be prepared for making individualized decisions on 
how to care for the patient.
The present and the future
As a medical community, we are in the center of the pandemic: 
for better and for worse. COVID-19 has already exposed major 
weaknesses in the system of public health management. We all know 
that the government has done too little [4, 5]. The health care system 
in our country, including resources, physicians, and nurses, is heavily 
underinvested. The media and politicians show us simply how easy 
it is to manipulate information in the current reality. It is not fair to 
use the pandemic for political purposes, to accuse medical staff of 
disseminating the virus, and to require that physicians and nurses 
work with COVID-19 patients while failing to provide them with 
personal protective equipment, security measures, and insurance.
It is now clear that when epidemiologists warned of a pathogen with 
pandemic potential, it was high time to make adequate decisions to 
support health care and reorganize social priorities for the general 
population [4]. Not everything has to be evidence-based; sometimes 
it is anticipation-based, and should never be evidence-biased.
Beyond the pandemic
We cannot fix what has already happened. We can hope and work for 
a better future [1]. For now: save the lives, treat the patients, teach 
successors, and publish your achievements. The pandemic will speed 
up the advancement of medical technologies. Safer or more effective 
oral compounds are ready for use. They will give the opportunity for 
a more successful and safer therapy, less complications, or home-
based therapy. The process of licensing and reimbursement of new 
drugs should be faster. Compounds licensed in the USA should 
be immediately approved in Europe. Drugs reimbursed in Europe 
should also be reimbursed in Poland. New immunotherapies are 
usually safer and more efficacious than conventional chemotherapy. 
Oral drugs are better and safer than intravenous medications, both 
for patients and hospitals. Prevention is cheaper than treatment of 
complications.
Prognostic models for the duration of the pandemic are changing 
every day and in every center. Each scenario is possible, but it will 
surely finish in one day. Request to refrain from going into unproven 
therapies or citing misleading data and hyped-up anecdotes on social 
media and television. Too many otherwise-intelligent people have 
been willing to throw the principles of evidence-based medicine into 
the trash [1].
An effective response to COVID-19 requires novel, more creative 
legal tools. With COVID-19 spreading in our communities, the time 
has come to devise and implement public health laws that emphasize 
support rather than restriction [5].
Call for papers on COVID-19
We are a medical, academic, didactic, and scientific community, 
responsible for the future of hematology and transfusion medicine 
in our country. We should document our experience. I urge you 
to submit papers describing your experience with the COVID-19 
pandemic. Brief Communication and Clinical Vignette provides you 
with an easy format to report your clinical cases as well as your 
experience in creating protective environment, with your antiviral 
strategy, and with safe treatment provided to patients.
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